Skip to main content
. Author manuscript; available in PMC: 2017 Dec 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):572–580. doi: 10.1097/QAI.0000000000001145

Table 1. Baseline characteristics of 263 mother-infant pairs.

Total*
N (%)
Antiretroviral randomization
 Maternal antiretroviral 129 (49)
 Infant nevirapine 134 (51)
Nutritional randomization
 No supplement 125 (48)
 Received supplement 138 (52)
Mothers:
Age (years)
 15-25 144 (55)
 26-35 105 (40)
 36-45 13 (5)
Education (primary school only) 173 (66)
Married 242 (92)
Parity ≥1 227 (86)
CD4+ count per mm3
 200-350 95 (36)
 351-500 81 (31)
 >500 87 (33)
Plasma viral load copies/ml
  ≤ 1,000 20 (8)
  1,001-10,000 60 (23)
  > 10,000 181 (69)
Hemoglobin <11 g/dl 160 (61)
Antiretroviral regimen**
 Nevirapine based 5 (4)
 Nelfinavir based 29 (26)
 Lopinavir/ritonavir based 78 (70)
Infants:
Sex (female) 139 (53)
Birth weight <2.5 kg 27 (10)
*

Maternal age is missing for 1 mother, baseline plasma viral load is missing for 2 mothers, and antiretroviral (ARV) regimen is missing for 17 mothers assigned to maternal ARVs

**

Among mothers randomized to maternal ARV arm